Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

New Britain-Based ObGyn Group Joins Women’s Health Connecticut


Women’s Health Connecticut (WHC), one of the nation’s largest and most successful single-specialty groups, announced today that New Britain OB/GYN, has joined its overall network. The move further solidifies WHC’s position as Connecticut’s premier ObGyn practice.

The addition of New Britain OB/GYN under WHC’s umbrella adds to WHC’s growth as one of the largest and most successful women’s health practices in the nation – with more than 270 providers and over 90 locations in Connecticut and Massachusetts. With New Britain OB/GYN joining, both organizations can collaborate to enhance their efforts in providing the highest quality care to patients in their respective communities. With New Britain OB/GYN’s privileges at The Hospital of Central Connecticut, this partnership now adds a 24th affiliate hospital to the WHC network.

Nancy Bernstein, President and CEO of Women’s Health Connecticut, stated “We look forward to our new partnership with New Britain OB/GYN. Our principal purpose is to support our providers in the women’s health field by empowering them to more effectively design and deliver optimal care for their patients.”

Gerard Roy, MD, spoke about joining WHC and the potential it brings. “We are excited to work with Women’s Health Connecticut and believe it will enhance our efforts to bring the most advanced, innovative, and highest quality medical care to our community. This partnership allows our providers to continue to advance the quality of our patient care while leveraging WHC’s considerable expertise in the business aspects of our practice.”

About Women’s Health Connecticut

Founded in 1997, Physicians for Women’s Health (d/b/a Women’s Health Connecticut) is currently one of the largest and most respected women’s health practices in the nation, with more than 270 highly-trained and devoted healthcare providers. By focusing solely on women’s health, WHC provides unsurpassed expertise and devotion to addressing the changing needs of women across Connecticut, and more recently into Massachusetts. Its commitment and united voice for women has been influential in the women’s health sector for more than 2 decades.

About New Britain OB/GYN

New Britain OB/GYN has been an ObGyn physician practice committed to promoting the health and well-being of women in a nurturing environment through supportive, compassionate and committed care. Its six providers will continue their reputation for offering a highly patient-centered environment, a caring experienced staff, comprehensive on-site services and a fully integrated team approach. New Britain OB/GYN currently has two offices located throughout central Connecticut in Southington and New Britain.

If you would like more information about this, please contact Leslie Stedman at 860/678-3400 or lstedman@womenshealthct.com.

Share article on social media or email:

Pet Week on Capitol Hill Goes Virtual to Celebrate Importance of Pets During the Pandemic


News Image

“Pets have become even more important during the coronavirus pandemic,” said Steven Feldman, Executive Director of HABRI. “Pet Week on Capitol Hill will feature conversations with Members of Congress and pet care leaders about the importance of pet ownership in America.”

Hosted by the Human Animal Bond Research Institute (HABRI), Pet Week on Capitol Hill will bring the power of pets to Capitol Hill, delivering the message to elected representatives that pets are important for human health and wellbeing, especially during these unprecedented times. In an effort to safeguard the health and safety of all, Pet Night on Capitol Hill, the popular, in-person annual reception has been converted to a series of virtual conversations to be held September 8-10, 2020.

“Pets have become even more important during the coronavirus pandemic,” said Steven Feldman, Executive Director of HABRI. “Pet Week on Capitol Hill will feature conversations with Members of Congress and pet care leaders about the importance of pet ownership in America.”

In addition to a wealth of information about pets and related policies and legislation that will strengthen the human-animal bond, Pet Week will still include the much-anticipated Cutest Pets on Capitol competition! Pet Week on Capitol Hill is a free event, with all programming streaming from http://www.PetNight.com.

The full schedule is listed below:

Tuesday, September 8, 2020

4:00 PM- 4:45 PM EDT

Pet Nation: The Importance of Pets in America

  • Mark Cushing Author, Pet Nation
  • Steven Feldman Executive Director, HABRI

Wednesday, September 9, 2020

12:00 PM- 12:45 PM EDT

Lifesaving Pet-Related Legislation: A Discussion Of Important Initiatives That Will Help Keep Pets And People Safe, Healthy And Happy Together

  • Dr. Kurt Venator, DVM, PhD, Chief Veterinary Officer, Nestlé Purina PetCare (and his puppy Emmie)
  • Nicole Forsyth, President & CEO, RedRover
  • Nicole Lanahan, Executive Director, Got Your Six Support Dogs

4:00 PM- 4:45 PM EDT

One Health Act: The Role of Veterinary Medicine in Preventing Future Pandemics

  • Representative Kurt Schrader (OR-5)

Thursday, September 10, 2020

12:00 PM- 12:45 PM EDT

Pet Ownership and Pet Industry Economics in the Post-COVID World

  • Steve King, President & CEO, American Pet Products Association
  • Dave Bolen Industry Specialist, Graham Partners

4:00 PM- 4:45 PM EDT

COVID-19 Impact on Pet Fostering and Adoption

  • Susanne Kogut, President, Petco Foundation

5:00 PM- 5:45 PM EDT

Cutest Pets on Capitol Hill: Honoring the Cutest Congressional Companions from Both Sides of the Aisle

  • Presented by the Animal Health Institute (AHI)

Please visit http://www.PetNight.com to add sessions to your calendars, submit questions to the speakers, and sign-up early for Pet Night on Capitol Hill 2021. All programs will be available on-demand after initial broadcast.

“We plan to be back with Pet Night on Capitol Hill next year to celebrate in person with the pets that we love so much,” added Feldman. “Until then, we hope that virtual Pet Week will be helpful, and that all of the participating pet care organizations will serve as valuable resources for our friends on Capitol Hill.”

About HABRI

The Human Animal Bond Research Institute (HABRI) is a not-for-profit organization that maintains the world’s largest online library of human-animal bond research and information; funds innovative research projects to scientifically document the health benefits of companion animals; and informs the public about human-animal bond research and the beneficial role of companion animals in society. For more information, please visit http://www.habri.org.

Share article on social media or email:

G-CON Launches New Standard POD® Product Line, Eliminating the Complexity of Cleanroom Construction Projects


g-con manufacturing prefabricated cleanrooms standard pods

G-CON Standard PODs

The Standard POD launch has been a major goal for us, and allows us to mass produce, which will reduce the delivery timeline and cost of cleanrooms.

G-CON Manufacturing, the global leader in prefabricated, flexible cleanroom solutions, today unveiled its new Standard POD product line. The Standard POD designs will maximize efficiencies related to production, qualification, delivery and cost reduction and eliminate the complexity of cleanroom construction projects.

G-CON’s standard POD portfolio encompasses six PODs, three different dimensions with bi-directional and uni-directional flow approaches and all featuring ISO 7 classification. These units can ably support development and clinical scale operations for cell therapies, formulation and filling, drug substance, etc. and meet the building block approach to allow for configuration and assembly of multiple units to meet clients’ segregation and space requirements.

PODs, which have gained accelerating popularity over the past 10 years due to their prefabricated and prequalified turnkey benefits, are now available as an off-the-shelf piece of equipment through the Standard POD product line. With standardization, these cleanrooms can be purchased at a set list price, inclusive of design and qualification, much like purchasing a car. In this approach, lengthy design phases are unnecessary, and the product is produced repetitively with standard parts from qualified vendors by an experienced work force. Commissioning and qualification are routine as well resulting in a delivery of three months from order.

“At G-CON we constantly strive to deliver biopharmaceutical processing spaces faster, as time is of essence for our clients and patients,” Maik Jornitz, CEO of G-CON stated. “The Standard POD launch has been a major goal for us, and allows us to mass produce, which will reduce the delivery timeline and cost of cleanrooms. These PODs will also provide repeatable CGMP compliant quality, instead of the variable results that occur with other cleanroom approaches.”

The launch advances G-CON’s recently announced BUILDING FOR LIFE™ campaign, a campaign dedicated to getting drug therapies to patients faster.

To request more information or to receive our Standard POD Catalog, please email sales@gconbio.com.

About G-CON Manufacturing

G-CON Manufacturing designs, builds and installs prefabricated G-CON POD® cleanrooms. G-CON’s POD portfolio provides cleanrooms in a number of dimensions for a variety of uses, from laboratory environments to personalized medicine and production process platforms. G-CON POD® cleanroom units surpass traditional cleanroom structures in scalability, mobility and the possibility of repurposing the PODs once the production process reaches its lifecycle end. For more information, please visit G-CON’s website at http://www.gconbio.com.

G-CON Manufacturing… BUILDING FOR LIFE

Share article on social media or email:

Nutrition App, Lifesum, and Amazon, Collaborate on New Technology that Allows Users to Test How Specific Foods Can Personally Impact Body Composition and Sleep


News Image

In the past, many people might have eaten a meal and felt groggy or lethargic later, but that was all we knew. This technology allows consumers to test how nutrition and diet directly impact the way we feel even days later. -Henrik Torstensson, CEO of Lifesum

The nutrition app, Lifesum has collaborated with Amazon on Amazon Halo, which allows consumers to test over time how specific foods directly impact their health and wellness. It’s all part of the new Amazon Halo Labs. In the Lifesum labs for Amazon Halo, each lab helps members understand how their nutritional habits impact other areas of their life, such as their body composition and sleeping patterns.

The CEO of Lifesum, Henrik Torstensson, says this new technology can help consumers connect the relationship between diet and sleep.

“This is the future of health and wellness technology and we are excited to work with Amazon on this new application in the wellness space,” says Torstensson. “In the past, many people might have eaten a meal and felt groggy or lethargic later, but that was all we knew. This technology allows consumers to test how nutrition and diet directly impact the way we feel even days later.”

Lifesum is introducing interactive nutritional challenges and health content in the Amazon Halo app, enabling users see how their nutrition may impact their mind, body, and overall well-being.

The in-house registered dietitian for Lifesum, Kajsa Ernestam, says their challenges and health content are designed to bring long-lasting behavioral change that will improve the overall health of consumers.

“Nutrition is always individualized by the person – there is no one diet or routine that fits everyone,” said Ernestam. “Together, Lifesum and Amazon Halo are helping users find the health and nutritional approach that works best for them.”

Melissa Cha, Vice President of Amazon Halo, says new collaboration with Lifesum gives consumers the opportunity to connect their nutrition to how they feel.

“Nutrition is a critical part of any health and wellness journey, so we are excited to offer Amazon Halo members labs from Lifesum’s team of experts,” said Cha. “Together, we will help customers discover what works best for them based on their individual needs.”

How Technology Helps Consumers Improve their Health

Amazon Halo Labs are 1-4 week challenges or experiments that help members discover healthier habits that work for them. Currently, Halo members will have access to 10 Lifesum-developed labs, which will guide them through simple, trackable nutrition-focused challenges that test the impact small changes can have on their health over time.

Each Lifesum Lab is backed by science and ranges in length from one to four weeks. For example, cutting down on ultra-processed foods – like candy, fast food and potato chips – can improve a person’s body composition and reduce a person’s risk for lifestyle-related diseases. Through the Halo app, members are encouraged to replace these ultra-processed foods with lean protein, complex carbs, healthy fats and lots of greens. At the end of the lab, members are able to see how their health metrics changed after this behavior shift.

In addition to labs from Lifesum, Amazon Halo members can choose from more than 100 science-backed labs created by health, mind, body and social life experts, helping users feel their best.

Amazon Halo is a new service dedicated to helping customers improve their individual health and wellness. It is anchored by a mobile app and an accompanying wrist band. With Amazon Halo, members can track their Activity and Sleep, analyze their Body composition and tone of voice, and discover labs that work best for them personally. Learn more at amazon.com/haloband.

The popular health and wellness app, Lifesum, has more than 45 million consumers hoping to improve the way they eat, drink and exercise. The app consistently ranks in the Top-10 in Health & Fitness on the App Store. Lifesum is a recipient of the Editor’s Choice award on the App Store.

About Lifesum

Whether the user’s goal is to get fitter, lose weight or just lead a healthier lifestyle, Lifesum shows consumers how changing small habits and implementing them in everyday life can improve their overall health. Lifesum emphasizes overall health benefits and the nutritional value of food, and continually gives users personalized feedback, helping them evaluate what works for them so they can successfully reach their health goals. Consumers can sign up for Lifesum by clicking here.

Media Contact:

Mark Macias

mmm@maciaspr.com

646-770-0541

Share article on social media or email:

HiDO Data Analytics Announces Advisory Board


“HiDO Data Analytics expects to be a leader in the emerging field of Tele-pharmacy driven by artificial intelligence. HiDO’s technology accelerates clinical trials and eliminates medication errors and has the potential to serve as a consumer health-hub,” said Arvind Subramanian.

HiDO data analytics, a company focused on accelerating drug development, eliminating medication errors, and ending medication waste, is pleased to announce the formation of its Advisory Board. This group of distinguished senior executives have helped shape the future of clinical trials, data analytics, point-of-care applications software, and telepharmacy. Advisory Board members include Arvind Subramanian, a veteran healthcare technology senior executive with former roles at Wolters Kluwer Health, ProVation Medical, and GE Medical Systems; Craig Lipset, former head of clinical innovation at Pfizer and a clinical trial innovator; Dr. Kathy Donneson, a former CALPERS chief health plan administrator and former colonel in the United States Air Force; and Dr. Martin Torres a pharmacy thought leader in academic research and telepharmacy.

“For an early-stage company, we have assembled an impressive advisory board to guide HiDO in its mission to launch a data analytics platform that will improve the clinical trials process by impacting data accuracy and medication adherence,” said Brandon Woolsey, CTO, HiDO.

“HiDO Data Analytics expects to be a leader in the emerging field of Tele-pharmacy driven by artificial intelligence. HiDO’s technology accelerates clinical trials and eliminates medication errors and has the potential to serve as a consumer health-hub. The team of engineers at HiDO Data Analytics is on the cusp of transforming coordinated care and significantly impacting costs across the healthcare continuum. The HiDO vision is to become the gold standard in remote healthcare monitoring,” said Arvind Subramanian, HiDO Data Analytics Advisor.

About HiDO Data Analytics

HiDO advanced data analytics, a company focused on accelerating drug development, eliminating medication errors and ending medication waste. The HiDO data analytics team includes experts in drug discovery and development, clinical research, biomedical informatics and artificial intelligence.

For more information, please visit https://hidohealth.com/

Related Links

https://hidohealth.com/

Share article on social media or email:

Center for Vein Restoration Committed to Peer-to-Peer Education and Increasing Awareness of CVI


News Image

While the National Summer Series has come to an end, CVR is continuing their educational webinars throughout the fall with the next webinar being held on September 22.

Center for Vein Restoration (CVR) concluded their National Summer Series of free 1.0 category one Continuing Medical Education (CME) credit webinars on August 20, 2020. The series, which featured six presentations by board-certified CVR physicians as presenters and Founder and CEO Dr. Sanjiv Lakhanpal has moderator and host, were held between May and August of 2020 and served an audience of over 1000 unique viewers. Topics ranged from lymphedema to leg pain, but all centered on diagnosing and treating one underlying cause: Chronic Venous Insufficiency (CVI).

Accredited CME offerings presented by CVR physicians have long been a cornerstone of CVR’s commitment to education. In past years, CME dinners, held in communities serviced by CVR and organized by Physician Liaisons, have provided local physicians an opportunity to earn up to 2.0 category one CME credits in a single evening and learn more about CVI, a condition suffered by over 40 million Americans.

Unable to convene such events safely in the age of COVID-19, CVR launched their National Summer Series in May, to allow physicians from across the country and internationally to engage with CVR physicians live in a webinar format on a variety of vein-related topics.

The webinars were wildly successful with the final event in the series, Pelvic Congestion Syndrome, presented by Dr. Peter Pappas, Vascular Surgeon, Regional Medical Director for Northern New Jersey, and Director of the Center for Vein Restoration’s Venous and Lymphatic Medicine fellowship program, drawing over 430 registrants. The audience included physicians from all fields of medicine, as well as renowned vein specialists from across the country.

“I am so proud to be able to offer this incredible educational opportunity to the worldwide community of physicians seeing patients suffering from chronic venous disorders,” said Dr. Lakhanpal. “We can only continue to redefine the care of patients with venous disorders by fostering an ongoing exchange – about current treatment options, case studies, and answering the questions of physicians specializing in other areas.”

For the presenting physicians, the webinar series is a chance to network with other doctors while showcasing their unique approach to patient care.

Of presenting, Dr. Pappas said, “Many physicians don’t think of CVI first when seeing a patient suffering from pelvic pain, or leg swelling – but is important to know the signs and symptoms. CVI is very treatable and manageable when caught early.”

Other presenters and topics covered during the summer series included:

  • Nick Morrison, MD, FACS, FACPh on “Modalities of Treatment for Chronic Venous Disease”
  • Zoe Deol, MD, FACS, DABVLM on “Venous Leg Ulcers”
  • Vinay Satwah, DO, RPVI on “Clinical Approach and Management for Phlebolymphedema”
  • Eddie Fernandez, MD, RPVI on “Skin Manifestations of Venous Disease & Differentials”
  • Sean Stewart, MD, MD on “Chronic Venous Insufficiency and Leg Pain”


While the National Summer Series has come to an end, CVR is continuing their educational webinars throughout the fall with the next webinar being held on September 22.

To learn more and attend CVR webinars, or watch recordings:


ABOUT VENOUS INSUFFICIENCY

Venous insufficiency, the cause of significant suffering due to the sequelae of venous hypertension, most commonly arises as achy, tired and heavy legs. It may or may not be associated with varicose veins, spider veins or skin changes including venous ulcerations and indiscriminately affects between 30–40 million Americans. Numerous factors including age, weight, prolonged sitting or standing, genetics or a history of DVT (blood clots) can increase the risk of developing this common and often underdiagnosed disorder. Treatment options have evolved to an array of minimally invasive procedures in an office setting.

ABOUT CENTER FOR VEIN RESTORATION

Center for Vein Restoration (CVR) is the largest physician-led practice treating vein disease in the country. Having performed its first procedure in 2007 under President and CEO Dr. Sanjiv Lakhanpal, Center for Vein Restoration has since become nationally recognized as the clinical leader in treating chronic venous insufficiency. With 90 centers and growing, CVR has over 600 employees and conducts over 200,000 patient interactions annually. To learn more about CVR and its mission, visit http://www.centerforvein.com or by phone at 1-800-FIX-LEGS.

Share article on social media or email:

NeoTract Designates Dr. Richard Bevan-Thomas as UroLift® Center of Excellence


News Image

“This designation recognizes Dr. Richard Bevan-Thomas as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Richard Bevan-Thomas, M.D., Urology Partners of North Texas in Arlington, TX, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Bevan-Thomas has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“This designation recognizes Dr. Richard Bevan-Thomas as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “We are pleased to see the continued acceptance of the UroLift System as a standard of care treatment that may allow men to discontinue the use of BPH medications and improve their quality of life.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

For Teleflex Incorporated: Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Qualidigm Winds Down Operations After 37 Years of Transforming the Quality, Safety, and Value of Healthcare


“While I am saddened by the direction of the organization, I am proud of our history, accomplishments, and our long-standing reputation as a high-performing Quality Improvement Organization.

Qualidigm, the mission-driven not-for-profit healthcare consulting company based in Wethersfield, Conn. has announced it is winding down operations. For over 37 years, Qualidigm has been a leading national healthcare consulting and research organization, providing quality improvement and patient safety services to transform care delivery and improve outcomes. As a result of recent business slowdown due to COVID-19, a shift in the federal administration’s focus, dramatic delays and reductions in federal funding, with no reliance on donations as a not-for-profit organization, Qualidigm’s operations are no longer sustainable. After much careful consideration, the Board of Directors made the responsible action to dissolve the company on October 1, 2020.

As a 501(c)(3) organization, a measure of success for the organization has been to reduce the financial burden of the federal government. Over the last decade, Qualidigm has assisted the Centers for Medicare & Medicaid Services in avoiding over $400M in anticipated costs through the programs the organization has implemented across New England alone.

“While I am saddened by the direction of the organization, I am proud of our history, accomplishments, and our long-standing reputation as a high-performing Quality Improvement Organization,” said Timothy Elwell, PhD, MBA, Qualidigm President and CEO. “We are grateful and appreciative of the countless trusted relationships with many stakeholders who are also committed to transforming the quality, safety, and value of healthcare by leading, collaborating, and aligning improvement efforts. We take pride in our collaboration with healthcare providers throughout New England to make significant improvements to the quality of healthcare delivery resulting in $8.00 saved for each $1.00 invested by the federal government in our programs,” said Dr. Elwell.

As Qualidigm prepares to close its final chapter, the focus now is to look to the future to identify opportunities for continuing the organization’s important contributions to the healthcare industry. Qualidigm is diligently working with clients to explore opportunities to transfer current programs and Qualidigm workforce to other like-mind healthcare organizations. Additionally, the organization will be distributing any remaining assets to St. Joseph’s College of Maine and Quinnipiac University, two entities who, after a thorough review process, support the Qualidigm mission and provide meaningful opportunities to memorialize Qualidigm’s impact into the future.

About Qualidigm:

With its corporate headquarters in Wethersfield, Conn. and locations in Maine, New Hampshire, Vermont, and Rhode Island, Qualidigm’s mission is to transform the quality, safety, and value of healthcare by leading, collaborating, and aligning improvement efforts. Qualidigm provides quality improvement, project management, evidence-based education and learning sessions, evaluation, and technical assistance services to clinicians, healthcare organizations, and communities. With over 37 years of experience improving healthcare delivery, the company is focused on leading the way to make New England the healthiest region in the United States. http://www.Qualidigm.org

Share article on social media or email:

Varicose Vein Treatments Launch at The Private Clinic’s Buckinghamshire Surgery


The Private Clinic has recently announced the introduction of minimally invasive varicose vein treatments at their Stoke Poges clinic in South Buckinghamshire. The range of newly introduced treatments are the most up-to-date methods available on the market today, requiring no general anaesthetic or large surgical incisions. The procedures are also simple and quick to complete on a walk-in, walk-out basis, giving local residents the chance to treat varicose veins in a hassle-free way.

The Private Clinic now offers a total of 5 minimally invasive treatments at their Stoke Poges clinic, which have been tried and tested over 7,000 times across the brand’s wider network of nationwide treatment locations. These minimally invasive methods contrast to traditional vein stripping procedures often used by the NHS, which have a history of causing considerable pain among patients along with long periods of downtime.

Thanks to the introduction of these procedures to The Private Clinic’s Stoke Poges venue, patients are now able to take advantage of the least invasive methods on a local level. The Private Clinic is a pioneer for one particular treatment, called EVLA (Endovenous Laser Ablation) which destroys dysfunctional varicose veins using ultrasound and lasers under local anaesthetic in the space of just a few hours. This sophisticated procedure, known as the Gold Standard of Varicose Vein treatments, according to the National Institute for Clinical Excellence (NICE), offers patients speedy recovery times along with a proven success rate of 95.4% after five years of the treatment being carried out.

The Private Clinic has carried out the highest number of operations using this advanced procedure, and by bringing it to patients at the Stoke Poges clinic, The Private Clinic has made it even easier for individuals to access a world-leading varicose vein service for patients in the South-East, while also offering the procedure at the brand’s already diverse network of countrywide locales. Other treatments now offered at the Stoke Poges clinic include Sclerotherapy, for smaller varicose veins, Phlebectomy for larger bulging veins, Cutera CoolGlide for spider and thread veins, and VenaSeal, a medical-grade glue treatment to close leaking veins.

These procedures are available at The Private Clinic’s Stoke Poges venue from September 2020, starting at £150 for a private consultation. For more information on The Private Clinic’s varicose vein treatments, visit: https://www.theprivateclinic.co.uk/treatments/veins/varicose-veins

All our varicose vein removal procedures at The Private Clinic are performed by highly qualified senior vascular surgeons, while the brand’s success rate of over 95% has earned it a reputation as one of the UK’s leading clinics in the varicose vein treatment field.

About The Private Clinic

Established in 1983, The Private Clinic is an independent healthcare provider offering a diverse range of cosmetic treatments across a network of award-winning UK-based clinics. For over 35 years, the clinic has offered the broadest range of advanced procedures available in the UK cosmetic sector – from hair transplants, varicose vein treatments, bunion surgery, breast enlargements / reductions, facelifts, liposuction and rhinoplasty to laser hair removal, acne treatments and anti-ageing cosmetic procedures.

The clinic sees over 15,000 new patients every year and performs over 10,000 procedures, with one of the highest – if not the highest – patients’ satisfaction in the sector. In 2019, the clinic secured a Trustpilot 9.4, 5-star rating, and 96% of customers would recommend the brand to their friends and family. This multi award winning provider has been awarded the Aesthetic Award for Best UK Clinic Group 2017 and MyFaceMyBody Best Cosmetic Surgery Practice in 2018. All of the brand’s clinics have GMC Registered Surgeons and are Care Quality Commission (CQC) Regulated.

Share article on social media or email:

Transmission Prevention with the Hilarious “Real Nurse Jackie”


News Image

Jackie will dive into the obvious and not so obvious risks of transmission when caring for the elderly. Each half-hour session will cover a specific area of transmission and provide valuable mitigation techniques to help reduce the risks.

Grane Rx–the leading provider of senior care pharmacy solutions–announced its upcoming webinar series on preventing transmission in elder care. This timely series is designed to help caregivers and providers navigate COVID-19 and other risks when caring for vulnerable populations.

The series will be hosted by Jacqueline Vance, “The Real Nurse Jackie”, a Registered Nurse, Certified Director of Nursing Administration in Long Term Care, Board-certified Infection Preventionist AND Stand-up Comedienne. Jackie is widely known in the healthcare community because of her reoccurring Blog in McKnight’s Long-term Care News and ability to infuse just about any topic with humor.

“We couldn’t be more delighted to have The Real Nurse Jackie hosting Grane Rx’s series on transmission mitigation. I think we can all use some levity right now. Jackie is just the person to break through the virtual fatigue with her entertaining delivery and subject matter expertise,” shared Grane Rx CEO Bob Rowland.

Jackie will dive into the obvious and not so obvious risks of transmission when caring for the elderly. Each half-hour session will cover a specific area of transmission and provide valuable mitigation techniques to help reduce the risks.

Webinar Series Schedule

Part 1. September 10, 1:00pm ET

Topic: Think your hands are clean? Think again…

Part 2. September 24, 2:00pm ET

Topic: Getting personal with your PPE

Part 3. October 8, 1:00pm ET

Topic: Caution! Beware of hidden sources… Don’t be a spreader

Registration is currently open. Grane Rx invites all administrators, directors, nurses, clinicians, physicians and other senior care providers to join us for this fun and informative series on transmission prevention.

REGISTRATION can be found at: https://us02web.zoom.us/webinar/register/WN_IWz7q6IkSGCHlRwmFcp-5w.

About Grane Rx

Grane Rx is a high-touch senior care pharmacy and medication management provider. Our end-to-end services include clinical consulting, staff training, on-going staff support, pharmacy transition facilitation, precision medication prescribing and state-of-the-art pharmacy automation. All of our solutions are designed to streamline senior care operations, optimize care and manage costs. We work closely with our partners to build a collaborative relationship and ensure a smooth pharmacy transition.

Share article on social media or email: